These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27262203)

  • 1. Use of Activated Carbon in Packaging to Attenuate Formaldehyde-Induced and Formic Acid-Induced Degradation and Reduce Gelatin Cross-Linking in Solid Dosage Forms.
    Colgan ST; Zelesky TC; Chen R; Likar MD; MacDonald BC; Hawkins JM; Carroll SC; Johnson GM; Space JS; Jensen JF; DeMatteo VA
    J Pharm Sci; 2016 Jul; 105(7):2027-31. PubMed ID: 27262203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
    Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
    J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
    Digenis GA; Gold TB; Shah VP
    J Pharm Sci; 1994 Jul; 83(7):915-21. PubMed ID: 7965669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of hydroalcoholic solutions of formaldehyde in preparation of acetylsalicylic acid gastro-resistant capsules.
    Pina ME; Sousa AT
    Drug Dev Ind Pharm; 2002 Apr; 28(4):443-9. PubMed ID: 12056537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D; Bindra DS
    Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of extent of formaldehyde-induced crosslinking in hard gelatin capsules by near-infrared spectrophotometry.
    Gold TB; Buice RG; Lodder RA; Digenis GA
    Pharm Res; 1997 Aug; 14(8):1046-50. PubMed ID: 9279887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of gelatin capsules with formaldehyde and other aldehydes: an FTIR spectroscopy study.
    Tengroth C; Gasslander U; Andersson FO; Jacobsson SP
    Pharm Dev Technol; 2005; 10(3):405-12. PubMed ID: 16176021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excipient Stability in Oral Solid Dosage Forms: A Review.
    Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA; Stach PE
    Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations.
    Stella VJ
    Pharm Res; 2013 Dec; 30(12):3018-28. PubMed ID: 23636838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.
    Meyer MC; Straughn AB; Mhatre RM; Hussain A; Shah VP; Bottom CB; Cole ET; Lesko LL; Mallinowski H; Williams RL
    Pharm Res; 2000 Aug; 17(8):962-6. PubMed ID: 11028942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of formaldehyde-induced crosslinking in soft elastic gelatin capsules using near-infrared spectrophotometry.
    Gold TB; Buice RG; Lodder RA; Digenis GA
    Pharm Dev Technol; 1998 May; 3(2):209-14. PubMed ID: 9653758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of reactive impurities in aqueous and neat polyethylene glycol 400 and effects of antioxidants and oxidation inducers.
    Hemenway JN; Carvalho TC; Rao VM; Wu Y; Levons JK; Narang AS; Paruchuri SR; Stamato HJ; Varia SA
    J Pharm Sci; 2012 Sep; 101(9):3305-18. PubMed ID: 22610374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
    Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
    J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
    Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
    Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.